NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘pharmaceuticals’

23 April 2014

Kala Pharmaceuticals scores $22.5m Series B

dollar envelope money Ysios Capital has led a $22.5m Series B round for Kala Pharmaceuticals, which is focused on developing ophthalmic products based on its mucus penetrating particle technology.

15 April 2014

Column Group nears $200m mark for second fund

biotech_lrg Biotech-focused investment firm The Column Group has passed the halfway mark for its $250m-targeting second venture capital fund, according to documents filed with US securities regulators.

8 April 2014

Lightstone Ventures secures more than $150m for debut fundp

life science test tube_sq Life sciences-focused venture capital firm Lightstone Ventures has passed the halfway mark for its debut fund, AltAssets has learned.

13 February 2014

Edgewater Capital Partners passes halfway point for $80m third fundp

Private equity firm Edgewater Capital Partners has passed the halfway mark for its latest fundraise, AltAssets has learned.

10 February 2014

Vatera Healthcare Partners leads $70m round for Melinta Therapeutics

pharmaceutical 12_sq Pharmaceutical company Melinta Therapeutics has raised $70m via its third round of funding, which was led by existing backer Vatera Healthcare Partners.

24 January 2014

Alibaba, Yunfeng back CITIC 21CN with $170m investment

china beijing_sq Chinese e-commerce company Alibaba Group and private equity firm Yunfeng have agreed to acquire a controlling interest in pharmaceutical information business CITIC 21CN.

22 January 2014

Warburg Pincus gets 3x return from JHP exit

pharmaceutical 12_sq Private equity firm Warburg Pincus is set to make a return of three times from the sale of specialty pharmaceutical company JHP Group.

22 January 2014

Venture capital-backed Dicerna prices IPO at $11 to $13 per share

dna Venture capital-backed RNA interference-based therapeutics developer Dicerna Pharmaceuticals has priced its IPO at $11 to $13 per share.

3 January 2014

Gene therapy company uniQure plans $75m Nasdaq IPO

stocks2_lrg Venture capital-backed gene therapy specialist uniQure plans to raise $75m via an IPO on the Nasdaq exchange, according to a filing with US securities regulators.

20 December 2013

Blackstone exits India’s Emcure Pharmaceuticals to Bain Capital

india5_lrg Blackstone has exited its investment in Indian company Emcure Pharmaceuticals to fellow private equity major Bain Capital.

Page 1 of 41234

Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014